San Francisco startup Structure Therapeutics is likewise focusing on an oral, after-day-to-day GLP-one drug called GSBR-1290—the drug surpassed Wall Road’s expectations in June when a mid-stage research confirmed normal weight loss of close to six% and it options to start out A furth